Amar U. Kishan, MD, discusses interim results from the phase 3 MIRAGE trial of magnetic resonance imaging–guided stereotactic body radiotherapy in prostate cancer.
Amar U. Kishan, MD
Advertisement
Articles by Amar U. Kishan, MD
Advertisement
Latest Updated Articles
Dr. Kishan on the MIRAGE Trial of MRI-Guided SBRT in Prostate CancerJanuary 30th 2023
Advertisement
Advertisement
Trending on OncLive
1
CELMoDs and Bispecifics Break Through Across Lymphomas and Leukemias at EHA 2026
2
Breast Cancer Experts Spotlight Practice-Informing and Thought-Provoking Data From ASCO 2026
3
Aglatimagene Besadenovec Plus EBRT Improves Prostate Cancer-Specific DFS
4
Hematologists Highlight Top Data From ASCO 2026
5